Ophthalmology · Fort Worth, TX
NPI
1427030139
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5000 Collinwood Ave
Fort Worth, TX, 76107
Phone (817) 732-5593
Groups this clinician bills Medicare through
Medicare paid, 2024
$196K
2,975 services
Medicare patients, 2024
619
Average age 75
Drug cost, 2024
$285K
2,103 prescriptions
Company payments, 2025
$211
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ann Ranelle was code 92014 (ophthalmological e&m), 450 times for 388 patients. In total Ann Ranelle billed 2,975 services in 46 codes, and Medicare paid $196K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 450 | 388 | $82.23 | $37K |
| 92136 Ultrasound - Nonspecific | Office | 187 | 94 | $18.48 | $3,456 |
| 92012 Ophthalmological E&M | Office | 157 | 132 | $55.38 | $8,694 |
| 66984 Cataract Surgery | Facility | 141 | 81 | $430.49 | $61K |
| 92133 Computerized Ophthalmic Imaging | Office | 126 | 117 | $25.85 | $3,258 |
| 92004 Ophthalmological E&M | Office | 102 | 102 | $94.91 | $9,681 |
| 92250 Angiography | Office | 96 | 94 | $25.09 | $2,408 |
| 92134 Computerized Ophthalmic Imaging | Office | 83 | 78 | $28.32 | $2,351 |
| 99214 Office E&M - Established | Office | 79 | 76 | $100.64 | $7,950 |
| 66821 Cataract Surgery | Office | 70 | 51 | $249.34 | $17K |
| 99213 Office E&M - Established | Office | 63 | 62 | $74.51 | $4,694 |
| 92083 Vision, Hearing, and Speech Services | Office | 53 | 53 | $37.85 | $2,006 |
| 92060 Vision, Hearing, and Speech Services | Office | 44 | 38 | $49.58 | $2,181 |
| 92082 Vision, Hearing, and Speech Services | Office | 40 | 40 | $37.57 | $1,503 |
| 76514 Ultrasound - Nonspecific | Office | 31 | 29 | $7.30 | $226 |
By year: 2022 $174K for 2,691 services; 2023 $170K for 2,870 services; 2024 $196K for 2,975 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ann Ranelle prescribed most often to Medicare patients was Latanoprost, with 356 prescriptions and refills. In total Ann Ranelle wrote 2,103 Medicare prescriptions that cost $285K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 356 | 854 | 110 | $2,644 |
| Moxifloxacin Moxifloxacin Hcl | 281 | 281 | 171 | $5,585 |
| Prednisolone Acetate Generic | 238 | 262 | 150 | $9,953 |
| Ketorolac Tromethamine Generic | 153 | 171 | 103 | $3,109 |
| Timolol Maleate Generic | 146 | 314 | 48 | $1,293 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 128 | 294 | 38 | $1,329 |
| Diclofenac Sodium Generic | 70 | 71 | 42 | $768 |
| Dorzolamide Hcl Generic | 69 | 133 | 18 | $1,441 |
| Restasis Cyclosporine | 62 | 114 | 26 | $70K |
| Brimonidine Tartrate Generic | 55 | 120 | 21 | $2,306 |
| Erythromycin Erythromycin Base | 49 | 49 | 35 | $556 |
| Difluprednate Generic | 33 | 33 | 20 | $2,480 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 27 | 28 | 24 | $316 |
| Lumigan Bimatoprost | 26 | 58 | 12 | $15K |
| Simbrinza Brinzolamide/Brimonidine Tart | 23 | 34 | Under 11 | $4,811 |
Brand drugs: 770 claims; generic drugs: 1,333 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ann Ranelle $211 ($211 in general payments such as food, travel and fees) from 6 companies. The largest payer was Biotissue Holdings Inc. with $65.87.
| Company | Payments | Amount |
|---|---|---|
| Biotissue Holdings Inc. | 3 | $65.87 |
| RxSight Inc RXST | 1 | $38.86 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $32.4 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $32.18 |
| Alcon Vision LLC ALC | 1 | $21.1 |
| Amgen Inc. AMGN | 1 | $20.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.